Depot medroxyprogesterone acetate and epithelial ovarian cancer: A multicentre case-control study

• Main Authors: Wilailak S., Vipupinyo C., Suraseranivong V., Chotivanich K., Kietpeerakool C., Tanapat Y., Therasakvichya S., Hamontri S., Linasmita V., Bunyapipat S., Chindavijak S., Ittiwisavakul K., Khemapech N., Suekwattana P., Thanapprapasr D., Lumbiganon P.
• 格式: 雜誌
• 出版: 2017
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859717358&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42847

Objective To evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors associated with the risk of EOC. Design A multicentre, case-control study. Setting Twelve hospitals located across Thailand. Population Three hun...